(Continued) Yancy et al Javed Butler Stony Brook University Division Chief of Cardiology Bayer CardioCell Medtronic Merck Novartis Relypsa Takeda Trevena Z Pharma Zensun Novartis None Amgen (DSMB) None None 7.3.2.10 and 7.3.2.11. Donald E. Casey, Jr Thomas Jefferson College of Population Health Adjunct Faculty; Alvarez & Marsal IPO4Health Principal and Founder None None None None None None None Monica M. Colvin University of Michigan Associate Professor of Medicine, Cardiology None None None None None None None Mark H. Drazner University of Texas Southwestern Medical Center Professor, Internal Medicine None None Trevena None DCRI/Otsuka UptoDate None None Gerasimos S. Filippatos National and Kapodistrian University of Athens; Attikon University Hospital, Department of Cardiology, Heart Failure Unit Professor of Cardiology None None None Bayer Bayer (DSMB) Novartis Servier Pharmaceuticals Vifor None None 7.3.2.10 and 7.3.2.11. Gregg C. Fonarow Ahmanson-UCLA Cardiomyopathy Center Director; UCLA Division of Cardiology Co-Chief Amgen Janssen Pharmaceuticals Novartis None None Novartis None None 7.3.2.10 and 7.3.2.11. Michael M. Givertz Brigham and Women s Hospital Professor of Medicine Merck Novartis None None None None None 7.3.2.10 and 7.3.2.11. Steven M. Hollenberg Cooper University Hospital Director, Coronary Care Unit, Professor of Medicine None None None None None None None JoAnn Lindenfeld Vanderbilt Heart and Vascular Institute Director, Advanced Heart Failure and Transplant Section Professor of Medicine Abbott Janssen Pharmaceuticals Novartis Relypsa ResMed None None AstraZeneca Novartis None None 7.3.2.10 and 7.3.2.11. 